Associate Professor of Clinical Psychiatry
Columbia University
Dr. Dakwar completed a fellowship in Addiction Psychiatry at Columbia and received a K23 award evaluating the ketamine infusions combined with mindfulness training to treat cocaine use disorders. Most recently, he is a principal investigator on several R01s evaluating ketamine for induction onto extended-release naltrexone for opioid use disorder as well as ketamine infusion to facilitate treatment for cocaine use disorder and alcohol use disorder.
Disclosure information not submitted.
Friday, October 14, 2022
10:00 AM – 1:00 PM ET